WBHF/CMS/HST/4T-124-2026 /DI/2026/380

TECHNICAL DATA SHEET

Tender NIT No. : HST/4T-124-2026/DI/2026/380 Dated: 19-02-2026

Tender inviting Authority : The Deputy Director of Health Services (E&S)

Bidder's Name :

Sl. No. Cat. No. Item Name with Specification , as provided in the Tender documents Accounting Unit Quoted as (Drug/Non-Drug) Item Item Specification, offered by the Bidder with documents Accounting Unit quoted by the Bidder in the BOQ Deviation of technical specification, if any in higher standard (It must be mentioned here) Certified by BIS/ IS/US FDA/FDA/European CE [Should be mentioned against each quoted item(s)] Valid documents to be uploaded in the tender Document. Mention the folder & Page No. Quoted as (Manufacturer/ Importer) for the item License No under which the item is endorsed (only for Drug Item) Name of the folder & Page No. in which Drug Endorsement/F-10, submitted, (only for Drug Item) Name of the folder & Page No. in which Market Std. Cert. (MSC), submitted (only for Drug Item) If MSC not submitted, mention the reason with proper documents& Page No. (only for Drug Item) Whether the quoted item(s) are tested in NABL Lab. / CDL or not (Yes/No) Remarks (page no of supportive Documents for non submission of any documents )

1 B30.1 Bupropion hydrochloride 150mg Tab. Strip of 10 Tabs

2 C48.2 Carboplatin Inj. 450 mg./ Vial Vial

3 H3.5 Haloperidol Tab. 0.25mg Strip of 10 Tabs

4 I6.1(a) Insulin (Human pre mixed ) Soluble & NPH combination (30 : 70) or (25:75)/ I.U. -in Vial(Maximum pack size allowed 10ml /vial) Per IU

5 I4.2(a) Insulin Glargine (rDNA 100 I.U./ml) -in Vial / PFS/Cartridge Per IU

6 I7.1 Insulin Soluble Inj. I.P.40 I.U. / ml in 10 ml Vial . Box of 20 Vials

7 N20.1 Nortriptyline 25mg Tab. Strip of 10 Tabs

8 Z1.2 Zinc Sulphate 20 mg. (Dispersable) Tab. Strip of 10 Tabs

Select, Excess (+), Less (-)

Tender Inviting Authority: The Deputy Director of Health Services (E&S),Central Medical Stores

Name of Work: E-TENDER FOR PROCUREMENT OF DRUG ITEMS UNDER TABLE-A, FOR TWO YEARS FROM THE DATE OF AOC.

Contract No: HST/4T-124-2026/DI/2026/380 Dated: 19-02-2026

Name of the Bidder/ Bidding Firm / Company :

Sl. No. Item Description Cat NO. Tentative Annual Requirement as per AU Accounting Unit (AU) Estimated Rate in Rs. P Addition / Deduction Addition / Deduction Values Currency Convertion against each Item Quoted Currency in INR / Other Currency Basic Rate should be as per Clause No. 16. (d), PG: 14 of the NIT in Rs. P Excise Duty in Rs. P GST in % Freight Charges ( Unloading & Stacking) in Rs. P Any Other Taxes/Duties/Levies in Rs. P Other Taxes 2 in Rs. P IIIrd Party i.e DGS&D / RITES etc Inspection Charges @0.34%+Service Tax in Rs. P Less for Cenvat Credit,if any respect of Supplies Under full Excise Duty Category in Rs. P

1 Bupropion hydrochloride 150mg Tab. B30.1 Strip of 10 Tabs Excess(+) Full Conversion INR

2 Carboplatin Inj. 450 mg./ Vial C48.2 Vial Excess(+) Full Conversion INR

3 Haloperidol Tab. 0.25mg H3.5 Strip of 10 Tabs Excess(+) Full Conversion INR

4 Insulin (Human pre mixed ) Soluble & NPH combination (30 : 70) or (25:75)/ I.U. -in Vial(Maximum pack size allowed 10ml /vial) I6.1(a) Per IU Excess(+) Full Conversion INR

5 Insulin Glargine (rDNA 100 I.U./ml) -in Vial / PFS/Cartridge I4.2(a) Per IU Excess(+) Full Conversion INR

6 Insulin Soluble Inj. I.P.40 I.U. / ml in 10 ml Vial . I7.1 Box of 20 Vials Excess(+) Full Conversion INR

7 Nortriptyline 25mg Tab. N20.1 Strip of 10 Tabs Excess(+) Full Conversion INR

8 Zinc Sulphate 20 mg. (Dispersable) Tab. Z1.2 Strip of 10 Tabs Excess(+) Full Conversion INR

200 Important Note: 1. All prospective bidders are requested to quote the rate in BOQ as per Accounting Unit & item specification as mentioned in the Table-A. Wrong Quoting of the rate in BOQ will be dealt with as per penal provisions of the T&C of the Tender. 2. Tendered quantity is just a tentative quantity and should not be treated as final. It may increase or decrease, as per need of the state. Keeping this in mind, the supplier is not allowed to seek termination of the Rate Contract after finishing supply of tendered quantity. 3. Quality of the product supplied, may be ascertained by testing / physical examination by the experts at any stage of the tender period. 4. The prospective Bidders of the said Tender are requested to make a declaration in Affidavit under Annexure VI(b) in case of sole manufacturer/importer (i.e. proprietary in nature). 5. If the Item(s) under sole manufacturer / importer is (are) Proprietary in nature, quarterly intimation is solicited from the approved Bidders positively regarding the status of their Item(s) Proprietary in nature, otherwise their Item(s) will be blocked in the SMIS. 6. In case of Tie Bid, decision will be taken by the TIA as per G.O. No. 2320-F(Y), dated 07.06.2022 issued from Finance Department Audit Branch (Group T).

Total in Figures

Quoted Rate in Figures Select %

Please Enable Macros to View BoQ information